Anesthetic Management of a Patient With Parkinson's Disease and a Deep Brain Stimulator Device for Hemiarthroplasty Surgery: A Case Report

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2023 Aug 7

PMID 37546148

Authors

Zainub Jooma

Affiliations

Soon will be listed here.

Abstract

Parkinson's disease (PD) is a common neurodegenerative disease. The multisystem effects of the disease and its pharmacological treatment have several anesthetic implications. With increasing duration of therapy, pharmacoresistance develops. Deep brain stimulation is a safe and effective treatment for symptom control in advanced PD. Its titratability and reversibility make it an attractive treatment option, and it has replaced surgical ablative procedures for advanced disease management. These devices have several implications in the perioperative period. A case is presented of a 75-year-old patient for urgent hemiarthroplasty surgery with advanced PD and a deep brain stimulator device in situ.

References

Yeoh T, Manninen P, Kalia S, Venkatraghavan L . In reply: Parkinsonism-hyperthermia syndrome and deep brain stimulation. Can J Anaesth. 2017; 64(6):677. DOI: 10.1007/s12630-017-0838-8. View

Yeoh T, Manninen P, Kalia S, Venkatraghavan L . Anesthesia considerations for patients with an implanted deep brain stimulator undergoing surgery: a review and update. Can J Anaesth. 2016; 64(3):308-319. DOI: 10.1007/s12630-016-0794-8. View

Boutet A, Chow C, Narang K, Elias G, Neudorfer C, Germann J . Improving Safety of MRI in Patients with Deep Brain Stimulation Devices. Radiology. 2020; 296(2):250-262. PMC: 7543718. DOI: 10.1148/radiol.2020192291. View

Roberts D, Lewis S . Considerations for general anaesthesia in Parkinson's disease. J Clin Neurosci. 2017; 48:34-41. DOI: 10.1016/j.jocn.2017.10.062. View

Liu C, Crnkovic A, Dalfino J, Singh L . Whether to Proceed With Deep Brain Stimulator Battery Change in a Patient With Signs of Potential Sepsis and Parkinson Hyperpyrexia Syndrome: A Case Report. A A Case Rep. 2017; 8(8):187-191. DOI: 10.1213/XAA.0000000000000462. View